Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sanofi (SNY) Shares Outstanding (Weighted Average) (2016 - 2026)

Sanofi's Shares Outstanding (Weighted Average) history spans 18 years, with the latest figure at $1.4 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 8.62% to $1.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.4 million, a 8.62% increase, with the full-year FY2025 number at $2.8 billion, up 112.31% from a year prior.
  • Shares Outstanding (Weighted Average) hit $1.4 million in Q1 2026 for Sanofi, down from $2.8 billion in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for SNY hit a ceiling of $2.8 billion in Q4 2025 and a floor of $847362.2 in Q1 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $761.9 million across 5 years, with a median of $634.7 million in 2025.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 99.94% in 2024 and later skyrocketed 125.85% in 2025.
  • Tracing SNY's Shares Outstanding (Weighted Average) over 5 years: stood at $1.3 billion in 2022, then grew by 5.44% to $1.3 billion in 2023, then dropped by 0.71% to $1.3 billion in 2024, then skyrocketed by 112.31% to $2.8 billion in 2025, then crashed by 99.95% to $1.4 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SNY at $1.4 million in Q1 2026, $2.8 billion in Q4 2025, and $5.5 million in Q3 2025.